AI in drug discovery
AI in drug discovery is the application of artificial intelligence, machine learning, and deep learning across the pharmaceutical pipeline to identify drug targets, design new molecules, predict protein…
Explore AI for Science through related topics and the articles other pages reference most.
Articles that also belong to these categories. Counts cover all of AI for Science.
Showing 1-12 of 12 articles
AI in drug discovery is the application of artificial intelligence, machine learning, and deep learning across the pharmaceutical pipeline to identify drug targets, design new molecules, predict protein…
AlphaFold 3 is a biomolecular structure prediction system developed jointly by Google DeepMind and Isomorphic Labs and published in Nature on May 8, 2024.
AlphaFold-Multimer is a deep learning system for predicting the three-dimensional structures of protein complexes, released by Google DeepMind in October 2021 as an extension of AlphaFold 2.
AlphaProteo is a machine learning system developed by Google DeepMind for the de novo design of high-affinity protein binders, novel proteins that attach tightly to a chosen target.
Boltz is a family of open-source biomolecular structure prediction models developed primarily at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) and the MIT Jameel Clinic.
Chai-1 is an open multimodal foundation model for biomolecular structure prediction released by the San Francisco startup Chai Discovery on 9 September 2024.
Claude for Life Sciences is an industry-specific offering from Anthropic that adapts its Claude models for scientific research and drug development, packaging connectors to laboratory and literature platforms…
OpenFold is an open source, trainable, GPU friendly PyTorch reimplementation of AlphaFold 2, developed initially by the AlQuraishi lab at Columbia University and then governed by the OpenFold Consortium
A protein language model (pLM) is a neural network trained on raw amino acid sequences using the same self-supervised objectives that power text models, with individual amino acids serving as tokens instead of…
RFdiffusion (short for RoseTTAFold diffusion) is a deep-learning system for de novo protein design developed at the University of Washington Institute for Protein Design (IPD) in David Baker's lab.
Rentosertib is an investigational oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) developed by Insilico Medicine for idiopathic pulmonary fibrosis (IPF)
RoseTTAFold is a deep-learning system for predicting the three-dimensional structures of proteins from amino acid sequence, developed at the Institute for Protein Design (IPD) at the University of Washington…